Authorization

What Happens When A Biotech Stock Blows Up: How Our Hedged Portfolio Method Limited The Damage With Cassava Sciences

What Happens When A Biotech Stock Blows Up: How Our Hedged Portfolio Method Limited The Damage With Cassava Sciences
Screen capture via Cassava Sciences' video for their Simulfilam Alzheimer's disease treatment.

When A Biotech Stock Goes The Wrong Way

In our last post (Corona Doom 2.0: Vaccine Mandate), we mentioned a biotech stock that has done well since our system picked it: coronavirus vaccine maker BioNTech SE (NASDAQ:BNTX), which is up 93% since it hit our top names in May. We're not always so lucky though. Another biotech stock our system picked this year, Cassava Sciences, Inc. (NASDAQ:SAVA) has struggled since. Maybe something similar will happen to the COVID vaccine makers in the future. Here's a look at what happens in our hedged portfolios when we get one wrong.

Responding To A Crash Prediction In July

In late July, the Fear & Greed Index hit the "Extreme Fear" level.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Сентябрь 2021    »
ПнВтСрЧтПтСбВс
 12345
6789101112
13141516171819
20212223242526
27282930